A cholinergic antagonist identifies a subclass of muscarinic receptors in isolated rat pancreatic acini.

Atropine, pirenzepine (PZ) and the novel antimuscarinic drug [11- [[2-(diethylamino)methyl]-1-piperidinyl]acetyl]-5,11-dihydro-6H- pyrido[2,3-b][1,4]benzodiazepine-6-one (AF-DX 116) were used to subclassify the pancreatic muscarinic receptor by correlating their effects on carbachol-mediated amylase release with their actions on the binding of [3H]N-methylscopolamine in rat pancreatic acini. Maximal stimulation of amylase release occurred at 3 microM carbachol. Atropine, PZ and AF-DX 116 inhibited carbachol-mediated amylase release with the following pA2 values: atropine = 9.1, PZ = 6.5 and AF-DX 116 = 5.7. There was parallel inhibition of [3H]N-methylscopolamine binding, with the following inhibition constants: atropine = 2.38 nM, PZ = 426 nM and AF-DX 116 = 3660 nM. Using the same animals, these compounds inhibited [3H]N-methylscopolamine binding in homogenates from both cerebral cortex and heart. The order of potency was the same in the cerebral cortex as in the pancreas: atropine = 0.67 nM, PZ = 85 nM and AF-DX 116 = 440 nM. However, in the cortex, the binding data with PZ also exhibited a high-affinity site with a KH value of 11 nM. In the heart, the order of potency was shifted to atropine greater than AF-DX 116 greater than PZ, with inhibition constants of 1.55, 12 and 110 nM, respectively. Thus, the muscarinic receptors in the pancreas and the heart exhibited the characteristics of the putative M2 receptor subtype, having lower affinities for PZ than the muscarinic receptors in the cerebral cortex. However, the heart had a significantly higher affinity for AF-DX 116.(ABSTRACT TRUNCATED AT 250 WORDS)

• Publication year

  1987

• Venue

  Journal of Pharmacology and Experimental Therapeutics

• Publication date

  1987-01-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/s0022-3565(25)22674-xPMID 2433426
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• SOME QUANTITATIVE USES OF DRUG ANTAGONISTS

  1997cited by this paper
• Cardioselective profile of AF-DX 116, a muscarine M2 receptor antagonist.

  1986cited by this paper
• [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. II. Characterization and regulation of antagonist binding to putative muscarinic subtypes.

  1986cited by this paper
• Binding profile of a novel cardioselective muscarine receptor antagonist, AF-DX 116, to membranes of peripheral tissues and brain in the rat.

  1986cited by this paper
• Comparative inhibitory effects of pirenzepine and atropine on cholinergic stimulation of exocrine and endocrine rat pancreas.

  1985cited by this paper
• A search for selective antagonists at M2 muscarinic receptors

  1985cited by this paper
• Pharmacological differences between the high-affinity muscarinic agonist binding states of the rat heart and cerebral cortex labeled with (+)-[3H]cismethyldioxolane.

  1984cited by this paper
• Characterization of muscarinic cholinergic receptors on rat pancreatic acini by N-[3H]methylscopolamine binding. Their relationship with calcium 45 efflux and amylase secretion.

  1984cited by this paper
• A unique regulatory profile and regional distribution of [3H]pirenzepine binding in the rat provide evidence for distinct M1 and M2 muscarinic receptor subtypes.

  1983cited by this paper
• Validation and statistical analysis of a computer modeling method for quantitative analysis of radioligand binding data for mixtures of pharmacological receptor subtypes.

  1982cited by this paper
• [3h]pirenzepine selectively identifies a high affinity population of muscarinic cholinergic receptors in the rat cerebral cortex.

  1982cited by this paper
• Regulation of pancreatic protein synthesis by cholecystokinin and calcium.

  1982cited by this paper
• Quantitative analysis of drug-receptor interactions: I. Determination of kinetic and equilibrium properties.

  1981cited by this paper
• Muscarinic receptor of rat pancreatic acini: [3H]QNB binding and amylase.

  1981cited by this paper
• Identification and characterization of receptors for secretagogues on pancreatic acinar cells.

  1981cited by this paper
• Pirenzepine distinguishes between different subclasses of muscarinic receptors

  1980cited by this paper
• Action of secretagogues on a new preparation of functionally intact, isolated pancreatic acini.

  1978cited by this paper
• The binding of antagonists to brain muscarinic receptors.

  1978cited by this paper
• Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction.

  1973cited by this paper
• A new and rapid method for the clinical determination of alpha-amylase activities in human serum and urine. Optimal conditions.

  1969cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper

• Distinct roles of M1 and M3 muscarinic acetylcholine receptors controlling oscillatory and non-oscillatory [Ca2+]i increase.

  2013cites this paper
• Distinct roles of M 1 and M 3 muscarinic acetylcholine receptors controlling oscillatory and non-oscillatory [ Ca 2 + ] i increase

  2013cites this paper
• Muscarinic agonists and antagonists: effects on gastrointestinal function.

  2012influential citation
• Galanin inhibits caerulein-stimulated pancreatic amylase secretion via cholinergic nerves and insulin.

  2009cites this paper
• Cholinergic Stimulation of Amylase Secretion from Pancreatic Acinar Cells Studied with Muscarinic Acetylcholine Receptor Mutant Mice

  2005cites this paper
• An embryonic chick pancreas organ culture model: characterization and neural control of exocrine release.

  2003cites this paper
• Control of Pancreatic Exocrine Secretion via Muscarinic Receptors: Which Subtype(s) Are Involved?

  2003cites this paper
• Muscarinic acetylcholine receptor subtypes mediating urinary bladder contractility and coupling to GTP binding proteins.

  1995cites this paper
• Functional sudomotor responses to cholinergic agonists and antagonists in the mouse.

  1995cites this paper
• Pharmacological profiles of the subtypes of muscarinic cholinoceptors that mediate aggregation of pigment in the melanophores of two species of catfish.

  1994cites this paper
• Muscarinic receptor characterization in differentiating avian exocrine cells.

  1994cites this paper
• Muscarinic M1 receptor mediated inhibition of GABA release from rat cerebral cortex.

  1994cites this paper
• Muscarinic M3 receptors mediate total inositol phosphates accumulation in murine HSDM1C1 fibrosarcoma cells.

  1993cites this paper
• Characterization of muscarinic receptors in rat kidney.

  1993cites this paper
• Muscarinic receptors in isolated guinea pig pancreatic ducts.

  1993cites this paper
• Muscarinic Autoreceptors of Torpedo Electric Organ Are of the M1 Subtype: Evidence by Radioligand Binding Using Selective Antagonists

  1992cites this paper
• Immunocytochemical localization of muscarinic acetylcholine receptors in the rat endocrine pancreas

  1992cites this paper
• Cloning of the rat M3, M4 and M5 muscarinic acetylcholine receptor genes by the polymerase chain reaction (PCR) and the pharmacological characterization of the expressed genes.

  1992cites this paper
• Muscarinic receptor subtype specificity of (N,N-dialkylamino)alkyl 2-cyclohexyl-2-phenylpropionates: cylexphenes (cyclohexyl-substituted aprophen analogues).

  1992cites this paper
• Regulation of pancreatic exocrine secretion in ruminants: a review.

  1992cites this paper
• Characterization of muscarinic receptor subtypes on rat pancreatic acini: pharmacological identification by secretory responses and binding studies.

  1992cites this paper
• Muscarinic M3 receptors mediate secretion from sweat glands in the rat.

  1991cites this paper
• The molecular properties of the M1 muscarinic receptor and its regulation of cytosolic calcium in a eukaryotic gene expression system.

  1991cites this paper
• Stereoselectivity of (R)- and (S)-hexahydro-difenidol binding to neuroblastoma M1, cardiac M2, pancreatic M3, and striatum M4 muscarinic receptors.

  1991cites this paper
• Characterization of muscarinic receptor subtype of rat eccrine sweat gland by autoradiography.

  1991cites this paper
• M3-subtype muscarinic receptor that controls intracellular calcium release and inositol phosphate accumulation in gastric parietal cells.

  1991cites this paper
• Release of digestive enzymes from isolated rat pancreatic acini following muscarinic stimulation: a comparative study with enzyme release and receptor binding.

  1991cites this paper
• Cardioselectivity of AQ-RA 741, a novel tricyclic antimuscarinic drug.

  1991cites this paper
• Effects of cycloheximide and tunicamycin on cell surface expression of pancreatic muscarinic acetylcholine receptors

  1990cites this paper
• Stereoselectivity of procyclidine binding to muscarinic receptor subtypes M1, M2 and M4.

  1990cites this paper
• Binding characteristics of the muscarinic receptor subtype in rabbit pancreas.

  1990cites this paper
• Characterization of muscarinic acetylcholine receptors in human labial salivary glands.

  1990cites this paper
• BINDING CHARACTERISTICS OF THE HUSCARINIC RECEPTOR SUBTYPE IN RABBIT PANCREAS A.J.G. van Zwam., P.H.G.M. Willemso, J.F.Rodrigues de Mirandam: J.J.H.H.M. de PontO and C.A.M. van Ginneken'

  1990cites this paper
• Sialic acid residues as catalysts for M2-muscarinic agonist-receptor interactions.

  1990cites this paper
• Cholinergic and adrenergic control of enzyme secretion in isolated rat pancreas

  1990cites this paper
• Binding of selective antagonists to four muscarinic receptors (M1 to M4) in rat forebrain.

  1990cites this paper
• Chapter 4. Central Muscarinic Ligands and Receptors

  1989cites this paper
• Characterization of the striatal M2 muscarinic receptor mediating inhibition of cyclic AMP using selective antagonists: a comparison with the brainstem M2 receptor.

  1989cites this paper
• Distance geometry of alpha-substituted 2,2-diphenylpropionate antimuscarinics.

  1989cites this paper
• Muscarinic-stimulated norepinephrine release and phosphoinositide hydrolysis in PC12 cells are independent events.

  1989cites this paper
• Identification and Characterization of Muscarinic Receptors in Cultured Human Pancreatic Carcinoma Cells

  1989cites this paper
• Pharmacological characterization of the M1 muscarinic receptors expressed in murine fibroblast B82 cells.

  1989cites this paper
• Characterization of cholinergic receptors mediating pepsinogen secretion from chief cells.

  1989cites this paper
• The structural and functional interrelationships of muscarinic acetylcholine receptor subtypes

  1989cites this paper
• Muscarinic receptors of the albino rabbit ciliary process.

  1989cites this paper
• Molecular pharmacology of muscarinic receptor heterogeneity.

  1989cites this paper
• Binary antidotes for organophosphate poisoning: aprophen analogues that are both antimuscarinics and carbamates.

  1989cites this paper
• Binding and functional characterization of the cardioselective muscarinic antagonist methoctramine.

  1988cites this paper
• Contribution of M2 alpha and M2 beta muscarinic receptors to the action of cholinergic stimuli on prostaglandin synthesis and mechanical function in the isolated rabbit heart.

  1988cites this paper
• Selective agents for muscarinic receptors linked to phosphoinositide breakdown.

  1988cites this paper
• Himbacine recognizes a high affinity subtype of M2 muscarinic cholinergic receptors in the rat cerebral cortex.

  1988cites this paper
• The muscarinic receptor subtype in mouse pancreatic B‐cells

  1988cites this paper
• Identification, localization and classification of muscarinic receptor subtypes in the gut.

  1988cites this paper
• Characterization of muscarinic receptor subtypes in human tissues.

  1988cites this paper
• Pharmacological characterization of muscarinic receptors involved in McN‐A‐343‐induced effects on intestinal motility and heart rate in conscious dogs

  1988cites this paper
• Heterogeneity of presynaptic muscarinic receptors located on different tissue preparations.

  1988cites this paper
• Desethylaprophen: a metabolite of aprophen with antimuscarinic activities.

  1988cites this paper
• Characterization of muscarinic receptors in guinea pig ileum longitudinal smooth muscle.

  1988cites this paper
• Characterization of muscarinic cholinergic receptor subtypes in human peripheral lung.

  1988cites this paper
• Distinct primary structures, ligand‐binding properties and tissue‐specific expression of four human muscarinic acetylcholine receptors.

  1987cites this paper
• Different antagonist binding properties of rat pancreatic and cardiac muscarinic receptors.

  1987cites this paper
• Characterization of muscarinic receptors in salivary and lacrimal glands of the rat.

  1987cites this paper
• Heterogeneity of the M1 muscarinic receptor subtype between peripheral lung and cerebral cortex demonstrated by the selective antagonist AF-DX 116.

  1987cites this paper
• [3H]AF-DX 116 labels subsets of muscarinic cholinergic receptors in rat brain and heart.

  1987cites this paper
• An M2 muscarinic receptor subtype coupled to both adenylyl cyclase and phosphoinositide turnover.

  1987cites this paper